Key points are not available for this paper at this time.
Lipid nanoparticles, or LNPs, including nanostructured lipid carriers (NLCs) and solid lipid nanoparticles (SLNs), attracted a lot of attention lately. SLNs were formed to circumvent the confines of the most common colloidal carriers because of their benefits, which include a favorable profile of release and precise administration of the drug with great physical stability. NLCs are the succeeding group of lipid nanoparticles with better capacity loading and durability. There are three possible NLC structural models. These LNPs may find usage in clinical medicine, research, cosmetics, and drug delivery.
Nanda et al. (Mon,) studied this question.